Back

Neutralizing Antibody to Omicron BA.1, BA.2 and BA.5 in COVID-19 Patients

2022-08-22 allergy and immunology Title + abstract only
View on medRxiv
Show abstract

Neutralizing antibody plays a key role in protective immunity against COVID-19. As increasingly distinct variants circulate, debate continues regarding the value of adding novel variants to SARS-CoV-2 vaccines. In this study, we have analyzed live virus neutralization titers against WA1, Delta, BA.1, BA.2, and BA.5 in 187 hospitalized patients infected with Delta or Omicron strains. This information will be useful in selection of the SARS-CoV-2 strains to include in an updated vaccine. Our resul...

Predicted journal destinations

1
Nature Communications
483 training papers
Top 3% 17.0%
2
Clinical Infectious Diseases
219 training papers
Top 3% 7.5%
3
Frontiers in Immunology
140 training papers
Top 2% 6.2%
4
The Journal of Infectious Diseases
137 training papers
Top 0.5% 6.2%
5
Cell
28 training papers
#1 6.2%
6
Vaccine
140 training papers
Top 2% 5.7%
7
PLOS ONE
1737 training papers
Top 78% 5.7%
8
Vaccines
131 training papers
Top 2% 4.8%
9
Cell Reports Medicine
49 training papers
Top 0.6% 3.7%
10
npj Vaccines
18 training papers
#1 2.9%
11
eLife
262 training papers
Top 17% 2.7%
12
Journal of Medical Virology
95 training papers
Top 5% 2.1%
13
The Journal of Immunology
19 training papers
Top 0.6% 1.9%
14
Scientific Reports
701 training papers
Top 82% 1.9%
15
iScience
74 training papers
Top 4% 1.9%
16
Journal of Clinical Investigation
50 training papers
Top 2% 1.8%
17
Nature Medicine
88 training papers
Top 6% 1.5%
18
JCI Insight
63 training papers
Top 5% 1.3%
19
New England Journal of Medicine
49 training papers
Top 2% 1.1%
20
Viruses
79 training papers
Top 7% 1.1%
21
Science Immunology
15 training papers
Top 0.6% 1.1%
22
The Lancet Infectious Diseases
57 training papers
Top 7% 0.9%
23
Proceedings of the National Academy of Sciences
100 training papers
Top 17% 0.9%
24
eBioMedicine
82 training papers
Top 14% 0.7%
25
Science Translational Medicine
40 training papers
Top 5% 0.7%